Decoding the Complexity of Cell and Gene Therapy
ONE PORTAL – MULTIPLE THERAPIES, MULTIPLE SITES, MULTIPLE STAKEHOLDERS

Hataali provides a comprehensive technical solution that simplifies the complexities of cell and gene therapies. Our modular, holistic solution streamlines the process for pharmaceutical companies, research institutions, medical centers, and logistics companies, ensuring the safety and efficacy of personalized treatments through digitization and automation utilizing blockchain and AI.

Germfree creates environments that serve life science innovation and advance global health. Germfree designs and manufactures flexible cGMP-compliant cleanroom buildings and high-containment facilities which are process or containment-ready upon deployment. Our facilities are designed to integrate with Germfree’s core equipment including our lines of interchangeable laminar flow hoods and containment equipment. Established in 1962 Germfree’s leading-edge fabrication technology, engineering teams and subject-matter experts are located at our 173,000 square foot (16,000 square meter) US manufacturing plant with installations in operation around the world.

Terumo Blood and Cell Technologies, a global leader in blood component, therapeutic apheresis and cellular therapy technologies, believes in the potential of blood and cells to do even more for patients than they do today. Terumo Blood and Cell Technologies’ business enables researchers, developers and manufacturers to create next-generation cell and gene therapies. We do this through flexible, automated solutions that help meet your evolving needs for reproducibility, quality and scale through the phases of development, from translational research to current good manufacturing practice (cGMP) for commercial manufacturing. One example, the Quantum’ Cell Expansion System, automates and optimizes cell culture to meet the needs of a variety of cell types in a consistent, controlled and functionally closed environment. We are also looking further downstream in the process to provide innovative solutions, like the Finia’ Fill and Finish System, to support your needs into the future.

Cognate BioServices is the leading CDMO for the development and manufacturing of autologous and allogeneic cell and gene therapy products. We are a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular immunotherapy and advance cell therapy companies. Cognate provides a unique combination of custom services to companies across all points of clinical and commercial development specializing in mid to late stage clinical trials and supporting our clients through product scale-up into commercial manufacturing. Cognate applies the knowledge and expertise of its business, scientific and technical teams to successfully develop autologous and allogeneic products across multiple cell-based technology platforms from start to finish.

Akron Biotech drives advanced therapy development and commercialization with high quality, industrial scale solutions. Akron’s strategic focus is supplying GMP-compliant ancillary materials and services to enable the advancement of cell and gene therapies. These include cytokines and growth factors, human sera and purified proteins, cryopreservation solutions, and custom development services. Beyond our pharmaceutical grade products, Akron is committed to providing solutions to our customers, with personalized service. An ISO 13485-certified company operating in line with cGMP guidelines and international standards, Akron provides advanced therapy developers the scale, compliance, and regulatory support to develop novel treatments.